Healthy volunteers test drug interactions in Early-Stage study
NCT ID NCT02402595
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This early-stage study looked at how a common antifungal drug, itraconazole, changes the levels of two experimental drugs (AVP-923 and AVP-786) in the blood. Twenty-four healthy adults took part to help researchers understand potential drug interactions. The goal was to gather safety and dosing information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vince and Associates Clinical Research, Inc.
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.